{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:16:06Z","timestamp":1790057766490,"version":"4.0.1"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00018-019-03171-9","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T17:02:26Z","timestamp":1559667746000},"page":"3083-3095","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Matrix metalloproteinases in the CNS: interferons get nervous"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5496-7610","authenticated-orcid":false,"given":"Sameeksha","family":"Chopra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5844-2731","authenticated-orcid":false,"given":"Christopher M.","family":"Overall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3429-4188","authenticated-orcid":false,"given":"Antoine","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,4]]},"reference":[{"key":"3171_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.tips.2013.02.004","volume":"34","author":"A Dufour","year":"2013","unstructured":"Dufour A, Overall CM (2013) Missing the target: matrix metalloproteinase antitargets in inflammation and cancer. Trends Pharmacol Sci 34:233\u2013242. https:\/\/doi.org\/10.1016\/j.tips.2013.02.004","journal-title":"Trends Pharmacol Sci"},{"key":"3171_CR2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nri3499","volume":"13","author":"R Khokha","year":"2013","unstructured":"Khokha R, Murthy A, Weiss A (2013) Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol 13:649\u2013665. https:\/\/doi.org\/10.1038\/nri3499","journal-title":"Nat Rev Immunol"},{"key":"3171_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nrd2308","volume":"6","author":"J Hu","year":"2007","unstructured":"Hu J, Van den Steen PE, Sang Q-XA, Opdenakker G (2007) Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov 6:480\u2013498. https:\/\/doi.org\/10.1038\/nrd2308","journal-title":"Nat Rev Drug Discov"},{"key":"3171_CR4","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrd2945","volume":"8","author":"GS Butler","year":"2009","unstructured":"Butler GS, Overall CM (2009) Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting. Nat Rev Drug Discov 8:935\u2013948. https:\/\/doi.org\/10.1038\/nrd2945","journal-title":"Nat Rev Drug Discov"},{"key":"3171_CR5","doi-asserted-by":"publisher","first-page":"10830","DOI":"10.1021\/bi901656f","volume":"48","author":"GS Butler","year":"2009","unstructured":"Butler GS, Overall CM (2009) Updated biological roles for matrix metalloproteinases and new \u201cintracellular\u201d substrates revealed by degradomics. Biochemistry 48:10830\u201310845. https:\/\/doi.org\/10.1021\/bi901656f","journal-title":"Biochemistry"},{"key":"3171_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrn3320","volume":"13","author":"GW Huntley","year":"2012","unstructured":"Huntley GW (2012) Synaptic circuit remodelling by matrix metalloproteinases in health and disease. Nat Rev Neurosci 13:743\u2013757. https:\/\/doi.org\/10.1038\/nrn3320","journal-title":"Nat Rev Neurosci"},{"key":"3171_CR7","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/cne.23965","volume":"524","author":"S Dauth","year":"2016","unstructured":"Dauth S, Grevesse T, Pantazopoulos H et al (2016) Extracellular matrix protein expression is brain region dependent. J Comp Neurol 524:1309\u20131336. https:\/\/doi.org\/10.1002\/cne.23965","journal-title":"J Comp Neurol"},{"key":"3171_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0166-2236(97)01169-7","volume":"21","author":"VW Yong","year":"1998","unstructured":"Yong VW, Krekoski CA, Forsyth PA et al (1998) Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 21:75\u201380","journal-title":"Trends Neurosci"},{"key":"3171_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/bs.pmbts.2017.04.002","volume":"148","author":"C De Luca","year":"2017","unstructured":"De Luca C, Papa M (2017) Matrix metalloproteinases, neural extracellular matrix, and central nervous system pathology. Prog Mol Biol Transl Sci 148:167\u2013202. https:\/\/doi.org\/10.1016\/bs.pmbts.2017.04.002","journal-title":"Prog Mol Biol Transl Sci"},{"key":"3171_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4103\/1673-5374.179030","volume":"11","author":"CD Small","year":"2016","unstructured":"Small CD, Crawford BD (2016) Matrix metalloproteinases in neural development: a phylogenetically diverse perspective. Neural Regen Res 11:357\u2013362. https:\/\/doi.org\/10.4103\/1673-5374.179030","journal-title":"Neural Regen Res"},{"key":"3171_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1750-3639.2008.00195.x","volume":"19","author":"D Bonneh-Barkay","year":"2009","unstructured":"Bonneh-Barkay D, Wiley CA (2009) Brain extracellular matrix in neurodegeneration. Brain Pathol 19:573\u2013585. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00195.x","journal-title":"Brain Pathol"},{"key":"3171_CR12","doi-asserted-by":"publisher","first-page":"789083","DOI":"10.1155\/2012\/789083","volume":"2012","author":"H Fujioka","year":"2012","unstructured":"Fujioka H, Dairyo Y, Yasunaga K-I, Emoto K (2012) Neural functions of matrix metalloproteinases: plasticity, neurogenesis, and disease. Biochem Res Int 2012:789083\u2013789088. https:\/\/doi.org\/10.1155\/2012\/789083","journal-title":"Biochem Res Int"},{"key":"3171_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.semcdb.2007.06.003","volume":"19","author":"SM Agrawal","year":"2008","unstructured":"Agrawal SM, Lau L, Yong VW (2008) MMPs in the central nervous system: where the good guys go bad. Semin Cell Dev Biol 19:42\u201351. https:\/\/doi.org\/10.1016\/j.semcdb.2007.06.003","journal-title":"Semin Cell Dev Biol"},{"key":"3171_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/35081571","volume":"2","author":"VW Yong","year":"2001","unstructured":"Yong VW, Power C, Forsyth P, Edwards DR (2001) Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2:502\u2013511. https:\/\/doi.org\/10.1038\/35081571","journal-title":"Nat Rev Neurosci"},{"key":"3171_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.febslet.2004.03.070","volume":"567","author":"J Dzwonek","year":"2004","unstructured":"Dzwonek J, Rylski M, Kaczmarek L (2004) Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett 567:129\u2013135. https:\/\/doi.org\/10.1016\/j.febslet.2004.03.070","journal-title":"FEBS Lett"},{"key":"3171_CR16","doi-asserted-by":"publisher","first-page":"H919","DOI":"10.1152\/ajpheart.00577.2012","volume":"303","author":"RP Iyer","year":"2012","unstructured":"Iyer RP, Patterson NL, Fields GB, Lindsey ML (2012) The history of matrix metalloproteinases: milestones, myths, and misperceptions. Am J Physiol Heart Circ Physiol 303:H919\u2013H930. https:\/\/doi.org\/10.1152\/ajpheart.00577.2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3171_CR17","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1523\/JNEUROSCI.4359-05.2006","volume":"26","author":"V Nagy","year":"2006","unstructured":"Nagy V, Bozdagi O, Matynia A et al (2006) Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci 26:1923\u20131934. https:\/\/doi.org\/10.1523\/JNEUROSCI.4359-05.2006","journal-title":"J Neurosci"},{"key":"3171_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fncel.2015.00073","volume":"9","author":"T Gorkiewicz","year":"2015","unstructured":"Gorkiewicz T, Balcerzyk M, Kaczmarek L, Knapska E (2015) Matrix metalloproteinase 9 (MMP-9) is indispensable for long term potentiation in the central and basal but not in the lateral nucleus of the amygdala. Front Cell Neurosci 9:73. https:\/\/doi.org\/10.3389\/fncel.2015.00073","journal-title":"Front Cell Neurosci"},{"key":"3171_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1152\/jn.00202.2007","volume":"98","author":"O Bozdagi","year":"2007","unstructured":"Bozdagi O, Nagy V, Kwei KT, Huntley GW (2007) In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. J Neurophysiol 98:334\u2013344. https:\/\/doi.org\/10.1152\/jn.00202.2007","journal-title":"J Neurophysiol"},{"key":"3171_CR20","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.celrep.2017.05.023","volume":"19","author":"M Bijata","year":"2017","unstructured":"Bijata M, Labus J, Guseva D et al (2017) Synaptic remodeling depends on signaling between serotonin receptors and the extracellular matrix. Cell Rep 19:1767\u20131782. https:\/\/doi.org\/10.1016\/j.celrep.2017.05.023","journal-title":"Cell Rep"},{"key":"3171_CR21","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.stemcr.2018.01.038","volume":"10","author":"X Shan","year":"2018","unstructured":"Shan X, Tomlinson L, Yang Q, Colognato H (2018) Distinct requirements for extracellular and intracellular MMP12 in the development of the adult V-SVZ neural stem cell niche. Stem Cell Reports 10:984\u2013999. https:\/\/doi.org\/10.1016\/j.stemcr.2018.01.038","journal-title":"Stem Cell Reports"},{"key":"3171_CR22","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1128\/MCB.00008-13","volume":"33","author":"B Kuzniewska","year":"2013","unstructured":"Kuzniewska B, Rejmak E, Malik AR et al (2013) Brain-derived neurotrophic factor induces matrix metalloproteinase 9 expression in neurons via the serum response factor\/c-Fos pathway. Mol Cell Biol 33:2149\u20132162. https:\/\/doi.org\/10.1128\/MCB.00008-13","journal-title":"Mol Cell Biol"},{"key":"3171_CR23","doi-asserted-by":"publisher","DOI":"10.14800\/ttnd.243","author":"PK Kamat","year":"2014","unstructured":"Kamat PK, Swarnkar S, Rai S et al (2014) Astrocyte mediated MMP-9 activation in the synapse dysfunction: an implication in Alzheimer disease. Ther Targets Neurol Dis. https:\/\/doi.org\/10.14800\/ttnd.243","journal-title":"Ther Targets Neurol Dis"},{"key":"3171_CR24","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/brain\/124.9.1743","volume":"124","author":"RL Lindberg","year":"2001","unstructured":"Lindberg RL, De Groot CJ, Montagne L et al (2001) The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 124:1743\u20131753","journal-title":"Brain"},{"key":"3171_CR25","doi-asserted-by":"publisher","first-page":"914104","DOI":"10.1155\/2013\/914104","volume":"2013","author":"H K\u00f6nnecke","year":"2013","unstructured":"K\u00f6nnecke H, Bechmann I (2013) The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas. Clin Dev Immunol 2013:914104\u2013914115. https:\/\/doi.org\/10.1155\/2013\/914104","journal-title":"Clin Dev Immunol"},{"key":"3171_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0165-5728(99)00094-6","volume":"99","author":"R Lichtinghagen","year":"1999","unstructured":"Lichtinghagen R, Seifert T, Kracke A et al (1999) Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis. J Neuroimmunol 99:19\u201326","journal-title":"J Neuroimmunol"},{"key":"3171_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1191\/135248506ms1274oa","volume":"12","author":"E Fainardi","year":"2006","unstructured":"Fainardi E, Castellazzi M, Bellini T et al (2006) Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Mult Scler 12:294\u2013301. https:\/\/doi.org\/10.1191\/135248506ms1274oa","journal-title":"Mult Scler"},{"key":"3171_CR28","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.str.2007.07.019","volume":"15","author":"G Rosenblum","year":"2007","unstructured":"Rosenblum G, Van den Steen PE, Cohen SR et al (2007) Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9\/gelatinase B. Structure\u00a015:1227\u20131236. https:\/\/doi.org\/10.1016\/j.str.2007.07.019","journal-title":"Structure"},{"key":"3171_CR29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.str.2007.10.001","volume":"15","author":"CM Overall","year":"2007","unstructured":"Overall CM, Butler GS (2007) Protease yoga: extreme flexibility of a matrix metalloproteinase. Structure\u00a015:1159\u20131161. https:\/\/doi.org\/10.1016\/j.str.2007.10.001","journal-title":"Structure"},{"key":"3171_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/9781118772287.ch8","volume-title":"Matrix Metalloproteinase Biology","author":"A Dufour","year":"2015","unstructured":"Dufour A, Overall CM (2015) Subtracting Matrix Out of the Equation: New Key Roles of Matrix Metalloproteinases in Innate Immunity and Disease. Matrix Metalloproteinase Biology. Wiley, Hoboken, pp 131\u2013152"},{"key":"3171_CR31","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41467-018-04717-4","volume":"9","author":"A Dufour","year":"2018","unstructured":"Dufour A, Bellac CL, Eckhard U et al (2018) C-terminal truncation of IFN-\u03b3 inhibits proinflammatory macrophage responses and is deficient in autoimmune disease. Nat Commun 9:2416. https:\/\/doi.org\/10.1038\/s41467-018-04717-4","journal-title":"Nat Commun"},{"key":"3171_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc1821","volume":"6","author":"CM Overall","year":"2006","unstructured":"Overall CM, Kleifeld O (2006) Tumour microenvironment\u2014opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6:227\u2013239. https:\/\/doi.org\/10.1038\/nrc1821","journal-title":"Nat Rev Cancer"},{"key":"3171_CR33","doi-asserted-by":"crossref","first-page":"21141","DOI":"10.1016\/S0021-9258(17)45338-5","volume":"265","author":"CM Overall","year":"1990","unstructured":"Overall CM, Sodek J (1990) Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. J Biol Chem 265:21141\u201321151","journal-title":"J Biol Chem"},{"key":"3171_CR34","first-page":"209","volume":"1","author":"CM Overall","year":"1992","unstructured":"Overall CM, Sodek J (1992) Reciprocal regulation of collagenase, 72\u00a0kDa-gelatinase, and TIMP gene expression and protein synthesis in human fibroblasts induced by concanavalin A. Matrix Suppl 1:209\u2013211","journal-title":"Matrix Suppl"},{"key":"3171_CR35","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/978-0-387-69057-5_26","volume-title":"The Cancer Degradome","author":"JH Cox","year":"2008","unstructured":"Cox JH, Overall CM (2008) Cytokine substrates: MMP regulation of inflammatory signaling molecules. The Cancer Degradome. Springer, New York, New York, NY, pp 519\u2013539"},{"key":"3171_CR36","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.1371\/journal.pone.0000312","volume":"2","author":"AM Tester","year":"2007","unstructured":"Tester AM, Cox JH, Connor AR et al (2007) LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PLoS One 2:e312. https:\/\/doi.org\/10.1371\/journal.pone.0000312","journal-title":"PLoS One"},{"key":"3171_CR37","doi-asserted-by":"publisher","first-page":"e1001869","DOI":"10.1371\/journal.pbio.1001869","volume":"12","author":"N Fortelny","year":"2014","unstructured":"Fortelny N, Cox JH, Kappelhoff R et al (2014) Network analyses reveal pervasive functional regulation between proteases in the human protease web. PLoS Biol 12:e1001869. https:\/\/doi.org\/10.1371\/journal.pbio.1001869","journal-title":"PLoS Biol"},{"key":"3171_CR38","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1182\/blood-2007-12-129080","volume":"112","author":"RA Dean","year":"2008","unstructured":"Dean RA, Cox JH, Bellac CL et al (2008) Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR\u2009+\u2009CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood 112:3455\u20133464. https:\/\/doi.org\/10.1182\/blood-2007-12-129080","journal-title":"Blood"},{"key":"3171_CR39","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1074\/jbc.M111.314609","volume":"287","author":"AE Starr","year":"2012","unstructured":"Starr AE, Dufour A, Maier J, Overall CM (2012) Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16. J Biol Chem 287:5848\u20135860. https:\/\/doi.org\/10.1074\/jbc.M111.314609","journal-title":"J Biol Chem"},{"key":"3171_CR40","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.289.5482.1202","volume":"289","author":"GA McQuibban","year":"2000","unstructured":"McQuibban GA, Gong JH, Tam EM et al (2000) Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289:1202\u20131206","journal-title":"Science"},{"key":"3171_CR41","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1182\/blood.V100.4.1160.h81602001160_1160_1167","volume":"100","author":"GA McQuibban","year":"2002","unstructured":"McQuibban GA, Gong J-H, Wong JP et al (2002) Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100:1160\u20131167","journal-title":"Blood"},{"key":"3171_CR42","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1074\/mcp.M600341-MCP200","volume":"6","author":"RA Dean","year":"2007","unstructured":"Dean RA, Overall CM (2007) Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. Mol Cell Proteomics 6:611\u2013623. https:\/\/doi.org\/10.1074\/mcp.M600341-MCP200","journal-title":"Mol Cell Proteomics"},{"key":"3171_CR43","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/jcp.21535","volume":"217","author":"A Dufour","year":"2008","unstructured":"Dufour A, Sampson NS, Zucker S, Cao J (2008) Role of the hemopexin domain of matrix metalloproteinases in cell migration. J Cell Physiol 217:643\u2013651. https:\/\/doi.org\/10.1002\/jcp.21535","journal-title":"J Cell Physiol"},{"key":"3171_CR44","doi-asserted-by":"publisher","first-page":"35944","DOI":"10.1074\/jbc.M109.091769","volume":"285","author":"A Dufour","year":"2010","unstructured":"Dufour A, Zucker S, Sampson NS et al (2010) Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides. J Biol Chem 285:35944\u201335956. https:\/\/doi.org\/10.1074\/jbc.M109.091769","journal-title":"J Biol Chem"},{"key":"3171_CR45","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1158\/0008-5472.CAN-10-4552","volume":"71","author":"A Dufour","year":"2011","unstructured":"Dufour A, Sampson NS, Li J et al (2011) Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9. Cancer Res 71:4977\u20134988. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4552","journal-title":"Cancer Res"},{"key":"3171_CR46","first-page":"79","volume":"151","author":"CM Overall","year":"2001","unstructured":"Overall CM (2001) Matrix metalloproteinase substrate binding domains, modules and exosites. Overview and experimental strategies. Methods Mol Biol 151:79\u2013120","journal-title":"Methods Mol Biol"},{"key":"3171_CR47","doi-asserted-by":"publisher","first-page":"24833","DOI":"10.1074\/jbc.M005631200","volume":"276","author":"SM Ellerbroek","year":"2001","unstructured":"Ellerbroek SM, Wu YI, Overall CM, Stack MS (2001) Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem 276:24833\u201324842. https:\/\/doi.org\/10.1074\/jbc.M005631200","journal-title":"J Biol Chem"},{"key":"3171_CR48","doi-asserted-by":"publisher","first-page":"39005","DOI":"10.1074\/jbc.M206874200","volume":"277","author":"EM Tam","year":"2002","unstructured":"Tam EM, Wu YI, Butler GS et al (2002) Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage. J Biol Chem 277:39005\u201339014. https:\/\/doi.org\/10.1074\/jbc.M206874200","journal-title":"J Biol Chem"},{"key":"3171_CR49","doi-asserted-by":"publisher","first-page":"43336","DOI":"10.1074\/jbc.M407186200","volume":"279","author":"EM Tam","year":"2004","unstructured":"Tam EM, Moore TR, Butler GS, Overall CM (2004) Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities. J Biol Chem 279:43336\u201343344. https:\/\/doi.org\/10.1074\/jbc.M407186200","journal-title":"J Biol Chem"},{"key":"3171_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0165-5728(92)90192-N","volume":"41","author":"K Gijbels","year":"1992","unstructured":"Gijbels K, Masure S, Carton H, Opdenakker G (1992) Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol 41:29\u201334","journal-title":"J Neuroimmunol"},{"key":"3171_CR51","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fncel.2015.00280","volume":"9","author":"SM Reinhard","year":"2015","unstructured":"Reinhard SM, Razak K, Ethell IM (2015) A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders. Front Cell Neurosci 9:280. https:\/\/doi.org\/10.3389\/fncel.2015.00280","journal-title":"Front Cell Neurosci"},{"key":"3171_CR52","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1093\/brain\/awg285","volume":"126","author":"A Bar-Or","year":"2003","unstructured":"Bar-Or A, Nuttall RK, Duddy M et al (2003) Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 126:2738\u20132749. https:\/\/doi.org\/10.1093\/brain\/awg285","journal-title":"Brain"},{"key":"3171_CR53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0165-5728(03)00006-7","volume":"136","author":"C Avolio","year":"2003","unstructured":"Avolio C, Ruggieri M, Giuliani F et al (2003) Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes. J Neuroimmunol 136:46\u201353","journal-title":"J Neuroimmunol"},{"key":"3171_CR54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jneuroim.2014.11.004","volume":"278","author":"LL Aung","year":"2015","unstructured":"Aung LL, Mouradian MM, Dhib-Jalbut S, Balashov KE (2015) MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a. J Neuroimmunol 278:185\u2013189. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.11.004","journal-title":"J Neuroimmunol"},{"key":"3171_CR55","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1084\/jem.20051342","volume":"203","author":"S Agrawal","year":"2006","unstructured":"Agrawal S, Anderson P, Durbeej M et al (2006) Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med 203:1007\u20131019. https:\/\/doi.org\/10.1084\/jem.20051342","journal-title":"J Exp Med"},{"key":"3171_CR56","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.brainres.2008.03.036","volume":"1214","author":"JI Alvarez","year":"2008","unstructured":"Alvarez JI, Teale JM (2008) Multiple expression of matrix metalloproteinases in murine neurocysticercosis: Implications for leukocyte migration through multiple central nervous system barriers. Brain Res 1214:145\u2013158. https:\/\/doi.org\/10.1016\/j.brainres.2008.03.036","journal-title":"Brain Res"},{"key":"3171_CR57","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00004647-199605000-00002","volume":"16","author":"GA Rosenberg","year":"1996","unstructured":"Rosenberg GA, Navratil M, Barone F, Feuerstein G (1996) Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 16:360\u2013366. https:\/\/doi.org\/10.1097\/00004647-199605000-00002","journal-title":"J Cereb Blood Flow Metab"},{"key":"3171_CR58","doi-asserted-by":"publisher","first-page":"16031","DOI":"10.1038\/s41598-017-16250-3","volume":"7","author":"S Brilha","year":"2017","unstructured":"Brilha S, Ong CWM, Weksler B et al (2017) Matrix metalloproteinase-9 activity and a downregulated Hedgehog pathway impair blood-brain barrier function in an in vitro model of CNS tuberculosis. Sci Rep 7:16031. https:\/\/doi.org\/10.1038\/s41598-017-16250-3","journal-title":"Sci Rep"},{"key":"3171_CR59","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semcdb.2015.01.002","volume":"38","author":"Y Serlin","year":"2015","unstructured":"Serlin Y, Shelef I, Knyazer B, Friedman A (2015) Anatomy and physiology of the blood\u2013brain barrier. Semin Cell Dev Biol 38:2\u20136. https:\/\/doi.org\/10.1016\/j.semcdb.2015.01.002","journal-title":"Semin Cell Dev Biol"},{"key":"3171_CR60","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1016\/j.febslet.2011.04.066","volume":"585","author":"C Larochelle","year":"2011","unstructured":"Larochelle C, Alvarez JI, Prat A (2011) How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett 585:3770\u20133780. https:\/\/doi.org\/10.1016\/j.febslet.2011.04.066","journal-title":"FEBS Lett"},{"key":"3171_CR61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jns.2006.11.021","volume":"259","author":"VW Yong","year":"2007","unstructured":"Yong VW, Zabad RK, Agrawal S et al (2007) Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators. J Neurol Sci 259:79\u201384. https:\/\/doi.org\/10.1016\/j.jns.2006.11.021","journal-title":"J Neurol Sci"},{"key":"3171_CR62","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2012","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B (2012) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164:1079\u20131106. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01302.x","journal-title":"Br J Pharmacol"},{"key":"3171_CR63","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2174\/1573406413666170906122803","volume":"14","author":"M Boziki","year":"2018","unstructured":"Boziki M, Grigoriadis N (2018) An update on the role of matrix metalloproteinases in the pathogenesis of multiple sclerosis. Med Chem 14:155\u2013169. https:\/\/doi.org\/10.2174\/1573406413666170906122803","journal-title":"Med Chem"},{"key":"3171_CR64","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/jnr.490360409","volume":"36","author":"K Gijbels","year":"1993","unstructured":"Gijbels K, Proost P, Masure S et al (1993) Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J Neurosci Res 36:432\u2013440. https:\/\/doi.org\/10.1002\/jnr.490360409","journal-title":"J Neurosci Res"},{"key":"3171_CR65","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1006\/jaut.2001.0505","volume":"16","author":"M Kouwenhoven","year":"2001","unstructured":"Kouwenhoven M, Ozenci V, Gomes A et al (2001) Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes. J Autoimmun 16:463\u2013470. https:\/\/doi.org\/10.1006\/jaut.2001.0505","journal-title":"J Autoimmun"},{"key":"3171_CR66","doi-asserted-by":"publisher","first-page":"e4952","DOI":"10.1371\/journal.pone.0004952","volume":"4","author":"SA Shiryaev","year":"2009","unstructured":"Shiryaev SA, Savinov AY, Cieplak P et al (2009) Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis. PLoS One 4:e4952. https:\/\/doi.org\/10.1371\/journal.pone.0004952","journal-title":"PLoS One"},{"key":"3171_CR67","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1006\/bbrc.1993.1540","volume":"192","author":"P Proost","year":"1993","unstructured":"Proost P, van Damme J, Opdenakker G (1993) Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. Biochem Biophys Res Commun 192:1175\u20131181","journal-title":"Biochem Biophys Res Commun"},{"key":"3171_CR68","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0165-5728(03)00217-0","volume":"141","author":"S Starckx","year":"2003","unstructured":"Starckx S, Van den Steen PE, Verbeek R et al (2003) A novel rationale for inhibition of gelatinase B in multiple sclerosis: MMP-9 destroys \u03b1B-crystallin and generates a promiscuous T cell epitope. J Neuroimmunol 141:47\u201357. https:\/\/doi.org\/10.1016\/S0165-5728(03)00217-0","journal-title":"J Neuroimmunol"},{"key":"3171_CR69","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s11064-006-9116-9","volume":"31","author":"CA D\u2019Souza","year":"2006","unstructured":"D\u2019Souza CA, Moscarello MA (2006) Differences in susceptibility of MBP charge isomers to digestion by stromelysin-1 (MMP-3) and release of an immunodominant epitope. Neurochem Res 31:1045\u20131054. https:\/\/doi.org\/10.1007\/s11064-006-9116-9","journal-title":"Neurochem Res"},{"key":"3171_CR70","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.1021\/bi962649f","volume":"36","author":"JM Boggs","year":"1997","unstructured":"Boggs JM, Yip PM, Rangaraj G, Jo E (1997) Effect of posttranslational modifications to myelin basic protein on its ability to aggregate acidic lipid vesicles. Biochemistry 36:5065\u20135071. https:\/\/doi.org\/10.1021\/bi962649f","journal-title":"Biochemistry"},{"key":"3171_CR71","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/358155a0","volume":"358","author":"PV Lehmann","year":"1992","unstructured":"Lehmann PV, Forsthuber T, Miller A, Sercarz EE (1992) Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155\u2013157. https:\/\/doi.org\/10.1038\/358155a0","journal-title":"Nature"},{"key":"3171_CR72","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.4049\/jimmunol.146.11.3757","volume":"146","author":"WJ Lipham","year":"1991","unstructured":"Lipham WJ, Redmond TM, Takahashi H et al (1991) Recognition of peptides that are immunopathogenic but cryptic. Mechanisms that allow lymphocytes sensitized against cryptic peptides to initiate pathogenic autoimmune processes. J Immunol 146:3757\u20133762","journal-title":"J Immunol"},{"key":"3171_CR73","doi-asserted-by":"publisher","first-page":"31418","DOI":"10.1074\/jbc.M111.249169","volume":"286","author":"GB Ferraro","year":"2011","unstructured":"Ferraro GB, Morrison CJ, Overall CM et al (2011) Membrane-type matrix metalloproteinase-3 regulates neuronal responsiveness to myelin through Nogo-66 receptor 1 cleavage. J Biol Chem 286:31418\u201331424. https:\/\/doi.org\/10.1074\/jbc.M111.249169","journal-title":"J Biol Chem"},{"key":"3171_CR74","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0304-3940(00)01418-X","volume":"291","author":"A Leake","year":"2000","unstructured":"Leake A, Morris CM, Whateley J (2000) Brain matrix metalloproteinase 1 levels are elevated in Alzheimer\u2019s disease. Neurosci Lett 291:201\u2013203","journal-title":"Neurosci Lett"},{"key":"3171_CR75","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jns.2009.05.025","volume":"285","author":"L Fang","year":"2009","unstructured":"Fang L, Huber-Abel F, Teuchert M et al (2009) Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS). J Neurol Sci 285:62\u201366. https:\/\/doi.org\/10.1016\/j.jns.2009.05.025","journal-title":"J Neurol Sci"},{"key":"3171_CR76","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0","volume":"46","author":"K Conant","year":"2001","unstructured":"Conant K, McArthur JC, Griffin DE et al (2001) Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol 46:391\u2013398. https:\/\/doi.org\/10.1002\/1531-8249(199909)46:3%3c391:AID-ANA15%3e3.0.CO;2-0","journal-title":"Ann Neurol"},{"key":"3171_CR77","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/nn1127","volume":"6","author":"K Zhang","year":"2003","unstructured":"Zhang K, McQuibban GA, Silva C et al (2003) HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 6:1064\u20131071. https:\/\/doi.org\/10.1038\/nn1127","journal-title":"Nat Neurosci"},{"key":"3171_CR78","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0304-3940(97)00859-8","volume":"238","author":"AW Clark","year":"1997","unstructured":"Clark AW, Krekoski CA, Bou SS et al (1997) Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett 238:53\u201356","journal-title":"Neurosci Lett"},{"key":"3171_CR79","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jneuroim.2005.10.010","volume":"172","author":"T Ichiyama","year":"2006","unstructured":"Ichiyama T, Kajimoto M, Suenaga N et al (2006) Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis. J Neuroimmunol 172:182\u2013186. https:\/\/doi.org\/10.1016\/j.jneuroim.2005.10.010","journal-title":"J Neuroimmunol"},{"key":"3171_CR80","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1468-1331.1994.tb00051.x","volume":"1","author":"L Paemen","year":"1994","unstructured":"Paemen L, Olsson T, S\u00f6derstr\u00f6m M et al (1994) Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases. Eur J Neurol 1:55\u201363. https:\/\/doi.org\/10.1111\/j.1468-1331.1994.tb00051.x","journal-title":"Eur J Neurol"},{"issue":"Pt 12","key":"3171_CR81","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1093\/brain\/121.12.2327","volume":"121","author":"D Leppert","year":"1998","unstructured":"Leppert D, Ford J, Stabler G et al (1998) Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 121(Pt 12):2327\u20132334","journal-title":"Brain"},{"key":"3171_CR82","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0165-5728(99)00166-6","volume":"102","author":"F Sellebjerg","year":"2000","unstructured":"Sellebjerg F, Madsen HO, Jensen CV et al (2000) CCR82 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis. J Neuroimmunol 102:98\u2013106","journal-title":"J Neuroimmunol"},{"key":"3171_CR83","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1191\/1352458502ms800oa","volume":"8","author":"GM Liuzzi","year":"2002","unstructured":"Liuzzi GM, Trojano M, Fanelli M et al (2002) Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis. Mult Scler 8:222\u2013228. https:\/\/doi.org\/10.1191\/1352458502ms800oa","journal-title":"Mult Scler"},{"key":"3171_CR84","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1474-4422(03)00587-8","volume":"2","author":"G Opdenakker","year":"2003","unstructured":"Opdenakker G, Nelissen I, Van Damme J (2003) Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis. Lancet Neurol 2:747\u2013756","journal-title":"Lancet Neurol"},{"key":"3171_CR85","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1006\/jaut.1999.0285","volume":"12","author":"V Ozenci","year":"1999","unstructured":"Ozenci V, Rinaldi L, Teleshova N et al (1999) Metalloproteinases and their tissue inhibitors in multiple sclerosis. J Autoimmun 12:297\u2013303. https:\/\/doi.org\/10.1006\/jaut.1999.0285","journal-title":"J Autoimmun"},{"key":"3171_CR86","doi-asserted-by":"crossref","unstructured":"Lee MA, Palace J, Stabler G et al (1999) Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. Brain 122(Pt 2):191\u2013197","DOI":"10.1093\/brain\/122.2.191"},{"key":"3171_CR87","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1742-2094-10-80","volume":"10","author":"Y-J Li","year":"2013","unstructured":"Li Y-J, Wang Z-H, Zhang B et al (2013) Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels. J Neuroinflammation 10:80. https:\/\/doi.org\/10.1186\/1742-2094-10-80","journal-title":"J Neuroinflammation"},{"key":"3171_CR88","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1021\/pr801012x","volume":"8","author":"E Cuadrado","year":"2009","unstructured":"Cuadrado E, Rosell A, Penalba A et al (2009) Vascular MMP-9\/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study. J Proteome Res 8:3191\u20133197. https:\/\/doi.org\/10.1021\/pr801012x","journal-title":"J Proteome Res"},{"key":"3171_CR89","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/jth.12312","volume":"11","author":"JA Rodr\u00edguez","year":"2013","unstructured":"Rodr\u00edguez JA, Sobrino T, Orbe J et al (2013) proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke. J Thromb Haemost 11:1464\u20131473. https:\/\/doi.org\/10.1111\/jth.12312","journal-title":"J Thromb Haemost"},{"key":"3171_CR90","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0165-5728(03)00036-5","volume":"138","author":"CMP Vos","year":"2003","unstructured":"Vos CMP, van Haastert ES, de Groot CJA et al (2003) Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions. J Neuroimmunol 138:106\u2013114","journal-title":"J Neuroimmunol"},{"key":"3171_CR91","doi-asserted-by":"publisher","first-page":"9124","DOI":"10.1074\/jbc.M109.071266","volume":"285","author":"S Rangaraju","year":"2010","unstructured":"Rangaraju S, Khoo KK, Feng Z-P et al (2010) Potassium channel modulation by a toxin domain in matrix metalloprotease 23. J Biol Chem 285:9124\u20139136. https:\/\/doi.org\/10.1074\/jbc.M109.071266","journal-title":"J Biol Chem"},{"key":"3171_CR92","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2202-9-83","volume":"9","author":"SR Werner","year":"2008","unstructured":"Werner SR, Dotzlaf JE, Smith RC (2008) MMP-28 as a regulator of myelination. BMC Neurosci 9:83. https:\/\/doi.org\/10.1186\/1471-2202-9-83","journal-title":"BMC Neurosci"},{"key":"3171_CR93","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1212\/WNL.53.7.1397","volume":"53","author":"E Waubant","year":"1999","unstructured":"Waubant E, Goodkin DE, Gee L et al (1999) Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology 53:1397\u20131401","journal-title":"Neurology"},{"key":"3171_CR94","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0165-5728(96)00210-X","volume":"74","author":"JM Clements","year":"1997","unstructured":"Clements JM, Cossins JA, Wells GM et al (1997) Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor. J Neuroimmunol 74:85\u201394","journal-title":"J Neuroimmunol"},{"key":"3171_CR95","doi-asserted-by":"publisher","first-page":"9841","DOI":"10.1523\/JNEUROSCI.1993-06.2006","volume":"26","author":"J-YC Hsu","year":"2006","unstructured":"Hsu J-YC, McKeon R, Goussev S et al (2006) Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J Neurosci 26:9841\u20139850. https:\/\/doi.org\/10.1523\/JNEUROSCI.1993-06.2006","journal-title":"J Neurosci"},{"key":"3171_CR96","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/NEN.0b013e3182294fad","volume":"70","author":"J Skuljec","year":"2011","unstructured":"Skuljec J, Gudi V, Ulrich R et al (2011) Matrix metalloproteinases and their tissue inhibitors in cuprizone-induced demyelination and remyelination of brain white and gray matter. J Neuropathol Exp Neurol 70:758\u2013769. https:\/\/doi.org\/10.1097\/NEN.0b013e3182294fad","journal-title":"J Neuropathol Exp Neurol"},{"key":"3171_CR97","first-page":"729","volume":"152","author":"A Pagenstecher","year":"1998","unstructured":"Pagenstecher A, Stalder AK, Kincaid CL et al (1998) Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 152:729\u2013741","journal-title":"Am J Pathol"},{"key":"3171_CR98","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nbd.2006.02.006","volume":"23","author":"KJ Gurney","year":"2006","unstructured":"Gurney KJ, Estrada EY, Rosenberg GA (2006) Blood\u2013brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol Dis 23:87\u201396. https:\/\/doi.org\/10.1016\/j.nbd.2006.02.006","journal-title":"Neurobiol Dis"},{"key":"3171_CR99","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2202-10-17","volume":"10","author":"LA Buhler","year":"2009","unstructured":"Buhler LA, Samara R, Guzman E et al (2009) Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis. BMC Neurosci 10:17. https:\/\/doi.org\/10.1186\/1471-2202-10-17","journal-title":"BMC Neurosci"},{"key":"3171_CR100","doi-asserted-by":"publisher","first-page":"9465","DOI":"10.1074\/jbc.M709522200","volume":"283","author":"AR Folgueras","year":"2008","unstructured":"Folgueras AR, Fueyo A, Garc\u00eda-Su\u00e1rez O et al (2008) Collagenase-2 deficiency or inhibition impairs experimental autoimmune encephalomyelitis in mice. J Biol Chem 283:9465\u20139474. https:\/\/doi.org\/10.1074\/jbc.M709522200","journal-title":"J Biol Chem"},{"key":"3171_CR101","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41598-017-00794-5","volume":"7","author":"A Kaminari","year":"2017","unstructured":"Kaminari A, Giannakas N, Tzinia A, Tsilibary EC (2017) Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer\u2019s disease. Sci Rep 7:683. https:\/\/doi.org\/10.1038\/s41598-017-00794-5","journal-title":"Sci Rep"},{"key":"3171_CR102","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00001756-200503150-00003","volume":"16","author":"M Dewil","year":"2005","unstructured":"Dewil M, Schurmans C, Starckx S et al (2005) Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis. NeuroReport 16:321\u2013324","journal-title":"NeuroReport"},{"key":"3171_CR103","doi-asserted-by":"publisher","first-page":"12963","DOI":"10.1523\/JNEUROSCI.3118-11.2011","volume":"31","author":"H Mizoguchi","year":"2011","unstructured":"Mizoguchi H, Nakade J, Tachibana M et al (2011) Matrix metalloproteinase-9 contributes to kindled seizure development in pentylenetetrazole-treated mice by converting pro-BDNF to mature BDNF in the hippocampus. J Neurosci 31:12963\u201312971. https:\/\/doi.org\/10.1523\/JNEUROSCI.3118-11.2011","journal-title":"J Neurosci"},{"key":"3171_CR104","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1083\/jcb.200708213","volume":"180","author":"GM Wilczynski","year":"2008","unstructured":"Wilczynski GM, Konopacki FA, Wilczek E et al (2008) Important role of matrix metalloproteinase 9 in epileptogenesis. J Cell Biol 180:1021\u20131035. https:\/\/doi.org\/10.1083\/jcb.200708213","journal-title":"J Cell Biol"},{"key":"3171_CR105","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1172\/JCI6886","volume":"104","author":"B Dubois","year":"1999","unstructured":"Dubois B, Masure S, Hurtenbach U et al (1999) Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Investig 104:1507\u20131515. https:\/\/doi.org\/10.1172\/JCI6886","journal-title":"J Clin Investig"},{"key":"3171_CR106","doi-asserted-by":"publisher","first-page":"11127","DOI":"10.1523\/JNEUROSCI.23-35-11127.2003","volume":"23","author":"PH Larsen","year":"2003","unstructured":"Larsen PH, Wells JE, Stallcup WB et al (2003) Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J Neurosci 23:11127\u201311135","journal-title":"J Neurosci"},{"key":"3171_CR107","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1097\/00004647-200012000-00007","volume":"20","author":"M Asahi","year":"2000","unstructured":"Asahi M, Asahi K, Jung JC et al (2000) Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20:1681\u20131689. https:\/\/doi.org\/10.1097\/00004647-200012000-00007","journal-title":"J Cereb Blood Flow Metab"},{"key":"3171_CR108","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1471-2202-8-93","volume":"8","author":"N Mitsios","year":"2007","unstructured":"Mitsios N, Saka M, Krupinski J et al (2007) A microarray study of gene and protein regulation in human and rat brain following middle cerebral artery occlusion. BMC Neurosci 8:93. https:\/\/doi.org\/10.1186\/1471-2202-8-93","journal-title":"BMC Neurosci"},{"key":"3171_CR109","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.neurobiolaging.2012.10.015","volume":"34","author":"Y Liu","year":"2013","unstructured":"Liu Y, Zhang M, Hao W et al (2013) Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain. Neurobiol Aging 34:1231\u20131239. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.10.015","journal-title":"Neurobiol Aging"},{"key":"3171_CR110","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1096\/fj.04-2030fje","volume":"19","author":"A Weaver","year":"2005","unstructured":"Weaver A, Goncalves da Silva A, Nuttall RK et al (2005) An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1\/Th2 polarization. FASEB J 19:1668\u20131670. https:\/\/doi.org\/10.1096\/fj.04-2030fje","journal-title":"FASEB J"},{"key":"3171_CR111","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.2353\/ajpath.2010.091081","volume":"177","author":"A Goncalves DaSilva","year":"2010","unstructured":"Goncalves DaSilva A, Liaw L, Yong VW (2010) Cleavage of osteopontin by matrix metalloproteinase-12 modulates experimental autoimmune encephalomyelitis disease in C57BL\/6 mice. Am J Pathol 177:1448\u20131458. https:\/\/doi.org\/10.2353\/ajpath.2010.091081","journal-title":"Am J Pathol"},{"key":"3171_CR112","doi-asserted-by":"publisher","first-page":"898","DOI":"10.2353\/ajpath.2009.080952","volume":"174","author":"A Goncalves DaSilva","year":"2009","unstructured":"Goncalves DaSilva A, Yong VW (2009) Matrix metalloproteinase-12 deficiency worsens relapsing-remitting experimental autoimmune encephalomyelitis in association with cytokine and chemokine dysregulation. Am J Pathol 174:898\u2013909. https:\/\/doi.org\/10.2353\/ajpath.2009.080952","journal-title":"Am J Pathol"},{"key":"3171_CR113","doi-asserted-by":"publisher","first-page":"9504","DOI":"10.1038\/srep09504","volume":"5","author":"B Chelluboina","year":"2015","unstructured":"Chelluboina B, Warhekar A, Dillard M et al (2015) Post-transcriptional inactivation of matrix metalloproteinase-12 after focal cerebral ischemia attenuates brain damage. Sci Rep 5:9504. https:\/\/doi.org\/10.1038\/srep09504","journal-title":"Sci Rep"},{"key":"3171_CR114","doi-asserted-by":"publisher","first-page":"10107","DOI":"10.1523\/JNEUROSCI.23-31-10107.2003","volume":"23","author":"JEA Wells","year":"2003","unstructured":"Wells JEA, Rice TK, Nuttall RK et al (2003) An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J Neurosci 23:10107\u201310115","journal-title":"J Neurosci"},{"key":"3171_CR115","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00018-015-1992-1","volume":"73","author":"K Baranger","year":"2016","unstructured":"Baranger K, Marchalant Y, Bonnet AE et al (2016) MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer\u2019s disease. Cell Mol Life Sci 73:217\u2013236. https:\/\/doi.org\/10.1007\/s00018-015-1992-1","journal-title":"Cell Mol Life Sci"},{"key":"3171_CR116","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0014-5793(03)01458-3","volume":"557","author":"K Komori","year":"2004","unstructured":"Komori K, Nonaka T, Okada A et al (2004) Absence of mechanical allodynia and Abeta-fiber sprouting after sciatic nerve injury in mice lacking membrane-type 5 matrix metalloproteinase. FEBS Lett 557:125\u2013128","journal-title":"FEBS Lett"},{"key":"3171_CR117","doi-asserted-by":"publisher","first-page":"16451","DOI":"10.1073\/pnas.0908507106","volume":"106","author":"AR Folgueras","year":"2009","unstructured":"Folgueras AR, Vald\u00e9s-S\u00e1nchez T, Llano E et al (2009) Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation. Proc Natl Acad Sci USA 106:16451\u201316456. https:\/\/doi.org\/10.1073\/pnas.0908507106","journal-title":"Proc Natl Acad Sci USA"},{"key":"3171_CR118","doi-asserted-by":"publisher","first-page":"30615","DOI":"10.1074\/jbc.M109.041244","volume":"284","author":"SA Shiryaev","year":"2009","unstructured":"Shiryaev SA, Remacle AG, Savinov AY et al (2009) Inflammatory proprotein convertase-matrix metalloproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis. J Biol Chem 284:30615\u201330626. https:\/\/doi.org\/10.1074\/jbc.M109.041244","journal-title":"J Biol Chem"},{"key":"3171_CR119","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/363718a0","volume":"363","author":"E Nedivi","year":"1993","unstructured":"Nedivi E, Hevroni D, Naot D et al (1993) Numerous candidate plasticity-related genes revealed by differential cDNA cloning. Nature 363:718\u2013722. https:\/\/doi.org\/10.1038\/363718a0","journal-title":"Nature"},{"key":"3171_CR120","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0014-5793(95)01358-X","volume":"377","author":"RN LePage","year":"1995","unstructured":"LePage RN, Fosang AJ, Fuller SJ et al (1995) Gelatinase A possesses a beta-secretase-like activity in cleaving the amyloid protein precursor of Alzheimer\u2019s disease. FEBS Lett 377:267\u2013270","journal-title":"FEBS Lett"},{"key":"3171_CR121","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/jb\/mvj054","volume":"139","author":"M Ahmad","year":"2006","unstructured":"Ahmad M, Takino T, Miyamori H et al (2006) Cleavage of amyloid-beta precursor protein (APP) by membrane-type matrix metalloproteinases. J Biochem 139:517\u2013526. https:\/\/doi.org\/10.1093\/jb\/mvj054","journal-title":"J Biochem"},{"key":"3171_CR122","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1074\/mcp.M800449-MCP200","volume":"8","author":"T Vaisar","year":"2009","unstructured":"Vaisar T, Kassim SY, Gomez IG et al (2009) MMP-9 sheds the beta2 integrin subunit (CD18) from macrophages. Mol Cell Proteomics 8:1044\u20131060. https:\/\/doi.org\/10.1074\/mcp.M800449-MCP200","journal-title":"Mol Cell Proteomics"},{"key":"3171_CR123","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.1021\/bi020643m","volume":"42","author":"S Higashi","year":"2003","unstructured":"Higashi S, Miyazaki K (2003) Novel processing of beta-amyloid precursor protein catalyzed by membrane type 1 matrix metalloproteinase releases a fragment lacking the inhibitor domain against gelatinase A. Biochemistry 42:6514\u20136526. https:\/\/doi.org\/10.1021\/bi020643m","journal-title":"Biochemistry"},{"key":"3171_CR124","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0002-9440(10)61727-0","volume":"159","author":"B Stix","year":"2001","unstructured":"Stix B, K\u00e4hne T, Sletten K et al (2001) Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3. Am J Pathol 159:561\u2013570. https:\/\/doi.org\/10.1016\/S0002-9440(10)61727-0","journal-title":"Am J Pathol"},{"key":"3171_CR125","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0165-5728(03)00217-0","volume":"141","author":"S Starckx","year":"2003","unstructured":"Starckx S, Van den Steen PE, Verbeek R et al (2003) A novel rationale for inhibition of gelatinase B in multiple sclerosis: MMP-9 destroys alpha B-crystallin and generates a promiscuous T cell epitope. J Neuroimmunol 141:47\u201357","journal-title":"J Neuroimmunol"},{"key":"3171_CR126","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.bbrc.2006.05.004","volume":"345","author":"D Zhong","year":"2006","unstructured":"Zhong D, Saito F, Saito Y et al (2006) Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan. Biochem Biophys Res Commun 345:867\u2013871. https:\/\/doi.org\/10.1016\/j.bbrc.2006.05.004","journal-title":"Biochem Biophys Res Commun"},{"key":"3171_CR127","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/hmg\/10.15.1563","volume":"10","author":"H Yamada","year":"2001","unstructured":"Yamada H, Saito F, Fukuta-Ohi H et al (2001) Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex. Hum Mol Genet 10:1563\u20131569","journal-title":"Hum Mol Genet"},{"key":"3171_CR128","doi-asserted-by":"publisher","first-page":"16036","DOI":"10.1074\/jbc.M700641200","volume":"282","author":"P Michaluk","year":"2007","unstructured":"Michaluk P, Kolodziej L, Mioduszewska B et al (2007) Beta-dystroglycan as a target for MMP-9, in response to enhanced neuronal activity. J Biol Chem 282:16036\u201316041. https:\/\/doi.org\/10.1074\/jbc.M700641200","journal-title":"J Biol Chem"},{"key":"3171_CR129","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1128\/MCB.01775-07","volume":"28","author":"GS Butler","year":"2008","unstructured":"Butler GS, Dean RA, Tam EM, Overall CM (2008) Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding. Mol Cell Biol 28:4896\u20134914. https:\/\/doi.org\/10.1128\/MCB.01775-07","journal-title":"Mol Cell Biol"},{"key":"3171_CR130","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1096\/fj.07-101402","volume":"22","author":"A Szklarczyk","year":"2008","unstructured":"Szklarczyk A, Ewaleifoh O, Beique J-C et al (2008) MMP-7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function. FASEB J 22:3757\u20133767. https:\/\/doi.org\/10.1096\/fj.07-101402","journal-title":"FASEB J"},{"key":"3171_CR131","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nm.3508","volume":"20","author":"DJ Marchant","year":"2014","unstructured":"Marchant DJ, Bellac CL, Moraes TJ et al (2014) A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity. Nat Med 20:493\u2013502. https:\/\/doi.org\/10.1038\/nm.3508","journal-title":"Nat Med"},{"key":"3171_CR132","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/brain\/awg129","volume":"126","author":"I Nelissen","year":"2003","unstructured":"Nelissen I, Martens E, Van den Steen PE et al (2003) Gelatinase B\/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy. Brain 126:1371\u20131381","journal-title":"Brain"},{"key":"3171_CR133","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1432-1033.1997.00751.x","volume":"250","author":"MP d\u2019Ortho","year":"1997","unstructured":"d\u2019Ortho MP, Will H, Atkinson S et al (1997) Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 250:751\u2013757","journal-title":"Eur J Biochem"},{"key":"3171_CR134","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.4049\/jimmunol.161.7.3340","volume":"161","author":"U Sch\u00f6nbeck","year":"1998","unstructured":"Sch\u00f6nbeck U, Mach F, Libby P (1998) Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 161:3340\u20133346","journal-title":"J Immunol"},{"key":"3171_CR135","doi-asserted-by":"publisher","first-page":"14657","DOI":"10.1074\/jbc.271.25.14657","volume":"271","author":"A Ito","year":"1996","unstructured":"Ito A, Mukaiyama A, Itoh Y et al (1996) Degradation of interleukin 1beta by matrix metalloproteinases. J Biol Chem 271:14657\u201314660","journal-title":"J Biol Chem"},{"key":"3171_CR136","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jneuroim.2007.11.001","volume":"193","author":"E Milward","year":"2008","unstructured":"Milward E, Kim KJ, Szklarczyk A et al (2008) Cleavage of myelin associated glycoprotein by matrix metalloproteinases. J Neuroimmunol 193:140\u2013148. https:\/\/doi.org\/10.1016\/j.jneuroim.2007.11.001","journal-title":"J Neuroimmunol"},{"key":"3171_CR137","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1006\/bbrc.1996.1677","volume":"228","author":"S Chandler","year":"1996","unstructured":"Chandler S, Cossins J, Lury J, Wells G (1996) Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem Biophys Res Commun 228:421\u2013429. https:\/\/doi.org\/10.1006\/bbrc.1996.1677","journal-title":"Biochem Biophys Res Commun"},{"key":"3171_CR138","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0304-3940(95)12173-0","volume":"201","author":"S Chandler","year":"1995","unstructured":"Chandler S, Coates R, Gearing A et al (1995) Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett 201:223\u2013226. https:\/\/doi.org\/10.1016\/0304-3940(95)12173-0","journal-title":"Neurosci Lett"},{"key":"3171_CR139","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001","volume":"21","author":"M Asahi","year":"2001","unstructured":"Asahi M, Wang X, Mori T et al (2001) Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood\u2013brain barrier and white matter components after cerebral ischemia. J Neurosci 21:7724\u20137732. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-19-07724.2001","journal-title":"J Neurosci"},{"key":"3171_CR140","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/j.1471-4159.2007.04625.x","volume":"102","author":"A Szklarczyk","year":"2007","unstructured":"Szklarczyk A, Oyler G, McKay R et al (2007) Cleavage of neuronal synaptosomal-associated protein of 25\u00a0kDa by exogenous matrix metalloproteinase-7. J Neurochem 102:1256\u20131263. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04625.x","journal-title":"J Neurochem"},{"key":"3171_CR141","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.expneurol.2008.10.010","volume":"215","author":"J Levin","year":"2009","unstructured":"Levin J, Giese A, Boetzel K et al (2009) Increased alpha-synuclein aggregation following limited cleavage by certain matrix metalloproteinases. Exp Neurol 215:201\u2013208. https:\/\/doi.org\/10.1016\/j.expneurol.2008.10.010","journal-title":"Exp Neurol"},{"key":"3171_CR142","doi-asserted-by":"publisher","first-page":"25216","DOI":"10.1074\/jbc.M503341200","volume":"280","author":"JY Sung","year":"2005","unstructured":"Sung JY, Park SM, Lee C-H et al (2005) Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases. J Biol Chem 280:25216\u201325224. https:\/\/doi.org\/10.1074\/jbc.M503341200","journal-title":"J Biol Chem"},{"key":"3171_CR143","first-page":"1865","volume":"27","author":"O Diekmann","year":"1994","unstructured":"Diekmann O, Tschesche H (1994) Degradation of kinins, angiotensins and substance P by polymorphonuclear matrix metalloproteinases MMP 8 and MMP 9. Braz J Med Biol Res 27:1865\u20131876","journal-title":"Braz J Med Biol Res"},{"key":"3171_CR144","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1046\/j.1471-4159.1995.64031312.x","volume":"64","author":"JR Backstrom","year":"2002","unstructured":"Backstrom JR, T\u00f6k\u00e9s ZA (2002) The 84-kDa form of human matrix metalloproteinase-9 degrades substance P and gelatin. J Neurochem 64:1312\u20131318. https:\/\/doi.org\/10.1046\/j.1471-4159.1995.64031312.x","journal-title":"J Neurochem"},{"issue":"Pt 4","key":"3171_CR145","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/brain\/123.4.698","volume":"123","author":"KA Harkness","year":"2000","unstructured":"Harkness KA, Adamson P, Sussman JD et al (2000) Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain 123(Pt 4):698\u2013709","journal-title":"Brain"},{"key":"3171_CR146","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.1073\/pnas.0305862101","volume":"101","author":"EM Tam","year":"2004","unstructured":"Tam EM, Morrison CJ, Wu YI et al (2004) Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc Natl Acad Sci USA 101:6917\u20136922. https:\/\/doi.org\/10.1073\/pnas.0305862101","journal-title":"Proc Natl Acad Sci USA"},{"key":"3171_CR147","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/370555a0","volume":"370","author":"AJ Gearing","year":"1994","unstructured":"Gearing AJ, Beckett P, Christodoulou M et al (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370:555\u2013557. https:\/\/doi.org\/10.1038\/370555a0","journal-title":"Nature"},{"key":"3171_CR148","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1172\/JCI7091","volume":"105","author":"H Haro","year":"2000","unstructured":"Haro H, Crawford HC, Fingleton B et al (2000) Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J Clin Investig 105:143\u2013150. https:\/\/doi.org\/10.1172\/JCI7091","journal-title":"J Clin Investig"},{"key":"3171_CR149","doi-asserted-by":"publisher","first-page":"14046","DOI":"10.1074\/jbc.275.19.14046","volume":"275","author":"WR English","year":"2000","unstructured":"English WR, Puente XS, Freije JM et al (2000) Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2. J Biol Chem 275:14046\u201314055","journal-title":"J Biol Chem"},{"key":"3171_CR150","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.tins.2008.10.003","volume":"32","author":"F Noorbakhsh","year":"2009","unstructured":"Noorbakhsh F, Overall CM, Power C (2009) Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology. Trends Neurosci 32:88\u2013100. https:\/\/doi.org\/10.1016\/j.tins.2008.10.003","journal-title":"Trends Neurosci"},{"key":"3171_CR151","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1086\/515342","volume":"178","author":"B Sporer","year":"1998","unstructured":"Sporer B, Paul R, Koedel U et al (1998) Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients. J Infect Dis 178:854\u2013857","journal-title":"J Infect Dis"},{"key":"3171_CR152","doi-asserted-by":"publisher","first-page":"43503","DOI":"10.1074\/jbc.M107736200","volume":"276","author":"GA McQuibban","year":"2001","unstructured":"McQuibban GA, Butler GS, Gong JH et al (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276:43503\u201343508. https:\/\/doi.org\/10.1074\/jbc.M107736200","journal-title":"J Biol Chem"},{"key":"3171_CR153","doi-asserted-by":"publisher","first-page":"19182","DOI":"10.1073\/pnas.0604678103","volume":"103","author":"D Vergote","year":"2006","unstructured":"Vergote D, Butler GS, Ooms M et al (2006) Proteolytic processing of SDF-1alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration. Proc Natl Acad Sci USA 103:19182\u201319187. https:\/\/doi.org\/10.1073\/pnas.0604678103","journal-title":"Proc Natl Acad Sci USA"},{"key":"3171_CR154","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1096\/fj.08-128819","volume":"23","author":"Y Zhu","year":"2009","unstructured":"Zhu Y, Vergote D, Pardo C et al (2009) CXCR154 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy. FASEB J 23:2928\u20132941. https:\/\/doi.org\/10.1096\/fj.08-128819","journal-title":"FASEB J"},{"key":"3171_CR155","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.0105-2896.2005.00252.x","volume":"204","author":"R Baccala","year":"2005","unstructured":"Baccala R, Kono DH, Theofilopoulos AN (2005) Interferons as pathogenic effectors in autoimmunity. Immunol Rev 204:9\u201326. https:\/\/doi.org\/10.1111\/j.0105-2896.2005.00252.x","journal-title":"Immunol Rev"},{"key":"3171_CR156","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2015.12.027","volume":"164","author":"CT Ng","year":"2016","unstructured":"Ng CT, Mendoza JL, Garcia KC, Oldstone MBA (2016) Alpha and beta type 1 interferon signaling: passage for diverse biologic outcomes. Cell 164:349\u2013352. https:\/\/doi.org\/10.1016\/j.cell.2015.12.027","journal-title":"Cell"},{"key":"3171_CR157","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1084\/jem.20101664","volume":"207","author":"G Trinchieri","year":"2010","unstructured":"Trinchieri G (2010) Type I interferon: friend or foe? J Exp Med 207:2053\u20132063. https:\/\/doi.org\/10.1084\/jem.20101664","journal-title":"J Exp Med"},{"key":"3171_CR158","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrrheum.2016.117","volume":"12","author":"MK Crow","year":"2016","unstructured":"Crow MK (2016) Autoimmunity: Interferon \u03b1 or \u03b2: which is the culprit in autoimmune disease? Nat Rev Rheumatol 12:439\u2013440. https:\/\/doi.org\/10.1038\/nrrheum.2016.117","journal-title":"Nat Rev Rheumatol"},{"key":"3171_CR159","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1161\/CIRCULATIONAHA.107.733238","volume":"117","author":"C Cheung","year":"2008","unstructured":"Cheung C, Marchant D, Walker EK-Y et al (2008) Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice. Circulation 117:1574\u20131582. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.733238","journal-title":"Circulation"},{"key":"3171_CR160","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa1608889","volume":"376","author":"LM Metz","year":"2017","unstructured":"Metz LM, Li DKB, Traboulsee AL et al (2017) Trial of minocycline in a clinically isolated syndrome of multiple sclerosis. N Engl J Med 376:2122\u20132133. https:\/\/doi.org\/10.1056\/NEJMoa1608889","journal-title":"N Engl J Med"},{"key":"3171_CR161","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/brain\/awh028","volume":"127","author":"F Gilli","year":"2004","unstructured":"Gilli F, Bertolotto A, Sala A et al (2004) Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs. Brain 127:259\u2013268. https:\/\/doi.org\/10.1093\/brain\/awh028","journal-title":"Brain"},{"key":"3171_CR162","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1084\/jem.170.3.1021","volume":"170","author":"KJ Hardy","year":"1989","unstructured":"Hardy KJ, Sawada T (1989) Human gamma interferon strongly upregulates its own gene expression in peripheral blood lymphocytes. J Exp Med 170:1021\u20131026","journal-title":"J Exp Med"},{"key":"3171_CR163","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/ni1126","volume":"5","author":"I Tassiulas","year":"2004","unstructured":"Tassiulas I, Hu X, Ho H et al (2004) Amplification of IFN-alpha-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors. Nat Immunol 5:1181\u20131189. https:\/\/doi.org\/10.1038\/ni1126","journal-title":"Nat Immunol"},{"key":"3171_CR164","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1073\/pnas.87.13.5183","volume":"87","author":"DR Johnson","year":"1990","unstructured":"Johnson DR, Pober JS (1990) Tumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy- and light-chain genes in vascular endothelium. Proc Natl Acad Sci USA 87:5183\u20135187","journal-title":"Proc Natl Acad Sci USA"},{"key":"3171_CR165","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(87)92863-7","volume":"1","author":"HS Panitch","year":"1987","unstructured":"Panitch HS, Hirsch RL, Haley AS, Johnson KP (1987) Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1:893\u2013895","journal-title":"Lancet"},{"key":"3171_CR166","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1212\/WNL.37.7.1097","volume":"37","author":"HS Panitch","year":"1987","unstructured":"Panitch HS, Hirsch RL, Schindler J, Johnson KP (1987) Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37:1097\u20131102","journal-title":"Neurology"},{"key":"3171_CR167","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/nm0997-1037","volume":"3","author":"MS Horwitz","year":"1997","unstructured":"Horwitz MS, Evans CF, Mcgavern DB et al (1997) Primary demyelination in transgenic mice expressing interferon-gamma. Nat Med 3:1037\u20131041","journal-title":"Nat Med"},{"key":"3171_CR168","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0002-9440(10)63126-4","volume":"164","author":"AA Dandekar","year":"2004","unstructured":"Dandekar AA, Anghelina D, Perlman S (2004) Bystander CD8 T-cell-mediated demyelination is interferon-gamma-dependent in a coronavirus model of multiple sclerosis. Am J Pathol 164:363\u2013369","journal-title":"Am J Pathol"},{"key":"3171_CR169","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/sj.bjc.6603043","volume":"94","author":"CM Overall","year":"2006","unstructured":"Overall CM, Kleifeld O (2006) Towards third generation matrix metalloproteinase inhibitors for cancer therapy. Br J Cancer 94:941\u2013946. https:\/\/doi.org\/10.1038\/sj.bjc.6603043","journal-title":"Br J Cancer"},{"key":"3171_CR170","doi-asserted-by":"publisher","first-page":"135245851772881","DOI":"10.1177\/1352458517728811","volume":"24","author":"S Faissner","year":"2017","unstructured":"Faissner S, Mahjoub Y, Mishra M et al (2017) Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease? Mult Scler 24:1352458517728811. https:\/\/doi.org\/10.1177\/1352458517728811","journal-title":"Mult Scler"},{"key":"3171_CR171","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa1608889","volume":"376","author":"LM Metz","year":"2017","unstructured":"Metz LM, Li DKB, Traboulsee AL et al (2017) Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis. N Engl J Med 376:2122\u20132133. https:\/\/doi.org\/10.1056\/NEJMoa1608889","journal-title":"N Engl J Med"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03171-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-019-03171-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03171-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T05:48:08Z","timestamp":1694929688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-019-03171-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,4]]},"references-count":171,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["3171"],"URL":"https:\/\/doi.org\/10.1007\/s00018-019-03171-9","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,4]]},"assertion":[{"value":"22 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}